chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue, headaches, lymphnodes swollen, pustules on site. Achy, malaise transported by ambulance. MD given oral medication. Loss of 4 days work, released no hospitalization.
Patient presented to clinic with the following adverse drug reactions; injection site of her right upper arm began to hurt at night,swell, and became red.  Patient received tetanus vaccine and flu or pneumovax.  Unknown if patient received the vaccination at clinic.
Localized reaction around injection site developing into reaction (urticaria) on most of upper torso.  From 0800 on the 6th until 0700 on the 7th urticaria spread from injection site to upper torso.  Was administered Solumedrol 125 mg x IV and 25 mg Benadryl x IV. Symptoms decreased within one hour.
Pt recvd 1st dose of Recomb on 16JAN91 & 3 hrs later exp dizziness, next day seen in clinic c/o dizziness, nausea, sweating, hot flashes, body aches, & back pain; pt alert & in no distress; pt elected not to recvd further Recomb vax;
Case was hospitalized for Covid 8 months after completing the primary Covid vaccine series. Brief Summary of Hospital Course Patient was admitted with 3 days of increasing cough and sputum production as well as fevers. This was in the setting of multiple prior infections and hospitalizations as documented in the admission and consult notes from 12/13/2021. Covid test was positive with a very low cycle threshold consistent with high viral load. Chest x-ray did show some peripheral opacities consistent with viral pneumonia. Fortunately, he was nonhypoxic. He was initiated on remdesivir.   Admission Covid serology was negative despite full vaccination for Covid including booster. He received a monoclonal antibodies because of this.   He was hospitalized to complete a full 5-day course of remdesivir. He generally did well during his hospitalization. He was never hypoxic. Symptoms improved.
Right side body numbness, 5 episodes to date, recover in 10 minutes from each episode. Flu and pneumonia shots received on 10/22/2003. First episode 10/25/03. Numbness starts in face and works down the body, right side only.
Information has been received from a physician who reported that a patient's mother told him that her 24 year old daughter, on an unspecified date was vaccinated with the third dose of GARDASIL (Lot not reported) and "shortly after vaccination" the patient complained of sore body and pain in joints and she was diagnosed with macrophagic myofascitis. It was reported that the patient could not get out of bed. She also developed skin lesions. The patient's muscle biopsy showed that the muscle contain aluminum. The physician also reported that she is no longer his patient. Additional information has been received from the physician, who stated that he "run into the patient's mother and she told him that her daughter was diagnosed with macrophagic myofascitis" at another medical center. The patient's mother stated that aluminum hydroxide was found in the patient's muscle. The physician also stated that the patient did not receive GARDASIL in his office. The physician felt that Macrophagic myofascitis and skin lesions were considered to be disabling. No additional information is expected.
Patient was sitting on cough, and experienced spinning and dizziness very badly. Then violent vomiting for 3 hours. Followed by itching on neck, arms. Left side of face and chest. Hives broke out on arms, face and chest. Itching continued for a few days. No treatment.
significant pain in the upper back/ pain in upper back; significant pain in the should/started to pain in the shoulder; significant pain in neck/started to pain in neck; significant pain gradually worked its way down the arm to the head and fingers/ on the right side it started to pain in the wrist in right arm; on a scale of 1-10 she would rate the pain as an 8; She had a low grade fever as well; She was kind of temporarily incapacitated like couldn't grasp things with right hand, couldn't write and things like that; This is a spontaneous report from a Consumer or other non-health professional (patient's husband). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6205) via an unspecified route of administration, administered in Left arm on 04Mar2021 (at the age of 72-year-old) as dose 1, single for covid-19 immunization. Medical history included hypertension, atrial fibrillation and She had quite a lot of blood loss from a cut and she was anemic at that time and she has recovered from that. No longer present but should be noted and that was about just about a year ago. Concomitant medications included METOPROLOL taken for primarily to control the heart rhythm and apixaban (ELIQUIS) an anticoagulant taken as a precautionary measure for atrial fibrillation both are from unknown start and stop date. Reporter stated he was calling about his wife. After the first shot taken by patient on left arm, on 05Mar2021, on the right side the patient experienced significant pain in the upper back, shoulder, neck and gradually worked its way down the arm to the hand and fingers, became quite painful. It started about the day after the shot. It was pretty severe, even with Tylenol and ice packs was still very painful. She had a low grade fever as well. On a scale of 1-10 she would rate the pain as an 8. Had some slight fever even after taking Tylenol and lying down with icepacks. For about ten days it went on fairly severe, bad enough. She spent a lot of time in bed for a couple of days. on an unspecified date in Mar2021, She was kind of temporarily incapacitated like couldn't grasp things with right hand, couldn't write and things like that. Treatment for events given with Tylenol, nothing else. It was reported events outcome was improved. Reporter wants to know the reaction to the vaccine that probably comes before that was whether unknown effect of vaccine or whether it was quite possibly something could be coincidental or could have a different cause. Her second dose is scheduled for the 25th and she was wondering that a reaction like this after the first one that the second one might be particularly severe, or she should either delay it or go for it. Seriousness was reported as no. Reporter was informed about the role of Pfizer Drug Safety and informed about Pfizer Medical Information department. Outcome of the events were resolving.  Follow-up attempts completed. No further information expected.
Became symptomatic on January 14th, 8 days after receiving first dose of moderna vaccine.  Tested positive for Covid19 on January 16th via rapids swab.
progression she had in fall; fall; This spontaneous case was reported by a patient and describes the occurrence of CONDITION AGGRAVATED (progression she had in fall) and FALL (fall) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included Stem cell therapy. Concurrent medical conditions included Immunocompromised.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (progression she had in fall) and FALL (fall). At the time of the report, CONDITION AGGRAVATED (progression she had in fall) and FALL (fall) outcome was unknown.            No concomitant medications were reported. Patient required an additional therapy because of the progression she had in fall.
This spontaneous report was received from a nurse and refers to unspecified patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB injection, lot# M001811, expiration date: 04-NOV-2018, lot# M014927, expiration date 18-FEB-2019 (dose and route of administration were not reported). The temperature excursion ranged between 32 and 36 degrees Fahrenheit and lasted 72 hours. There was no previous temperature excursion. Digital data logger was not used. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA005129: US-009507513-1703USA005128: US-009507513-1703USA005126: US-009507513-1703USA000842.
Right eye blurry vision and headache after. Next day 1 hour into school started with blurry vision in right eye with aura.
Patient comes in the pharmacy on 3/25/12 stating that his arm, on site of vaccination is swollen, red & hard, with pain.
Patient recieved 1st dose on 01-Apr-2021 and second dose on 07-May-2021.; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient recieved 1st dose on 01-Apr-2021 and second dose on 07-May-2021.) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A, 043B21A and 068H21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient recieved 1st dose on 01-Apr-2021 and second dose on 07-May-2021.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient recieved 1st dose on 01-Apr-2021 and second dose on 07-May-2021.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Treatment details were not reported by the reporter.   This case was linked to MOD-2022-604636 (Patient Link).
Had booster COVID vaccine 9/24/21 with initial side effects of HA, fatigue, low grade fever for 36hrs.On 9/27/21 early am she noticed pain under rt arm with pain radiating down anterior upper arm and forearm. She has taken 400mg ibuprofen but still with lymphadenopathy and discomfort. Recommended she add ice frequently under rt arm and continue with OTC pain meds.
On January 29, I had Covid arm on the arm that the vaccination was given. Swollen lymph nodes on my armpit and a weakness feeling on the right side(arm and leg). On the evening of February 5, while taking a shower, I felt a stinging sensation on my right side and felt small bumps. I went to an Urgent Care the following day and was diagnosed with shingles. I was prescribed Valtrex for 7 days.
This spontaneous report as received from a nurse refers to a 38 year old patient. Medical history and concurrent conditions were not reported. On 17-JAN-2014, the patient was vaccinated with PNEUMOVAX 23 lot # J005067; expiration date: 17-JAN-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored PNEUMOVAX 23 was administered to patient. No adverse effects reported. On 13-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, PNEUMOVAX 23 was stored of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded 51.8 degrees F. On 22-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours ((12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, PNEUMOVAX 23 the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
little bumps on the top of the left hand; burning sensation from the left shoulder to the elbow / burning extended down the arm all the way to the top of the left hand; had redness and burning sensation from the left shoulder to the elbow; This case was reported by a pharmacist via call center representative and described the occurrence of papular rash in a 77-year-old male patient who received Herpes zoster (Shingrix) (batch number PF454, expiry date 26th January 2022) for prophylaxis.   On 25th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 26th August 2020, 1 days after receiving Shingrix, the patient experienced burning sensation and erythema. On 27th August 2020, the patient experienced papular rash. On an unknown date, the outcome of the papular rash was unknown and the outcome of the burning sensation and erythema were recovered/resolved.   It was unknown if the reporter considered the papular rash, burning sensation and erythema to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix vaccine on left deltoid via intramuscularly and around the next day, the customer had redness and burning sensation from the left shoulder to the elbow and the following day the redness and burning extended down the arm all the way to the top of the left hand. Also he had some little bumps on the top of the left hand. The events was lasted for a week. The reporter consented to follow up.
fell; he was in pain; injured his shoulder; This is a spontaneous report from a contactable consumer. This male consumer (patient) reported via medical information team.   A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date on Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date on 2021, the patient fell and got injured and was in the hospital. The patient Fell and injured shoulder. He said that he was in pain and had to go to surgery but he feels better now. He is asking if it is still okay for him to get the second shot. He is asking if it is okay for him to have the Johnson & Johnson COVID Vaccine since it would only be one dose. He said that he was in pain and had to go to surgery, but he felt better now. He was asking if it is okay for him to have the Johnson & Johnson COVID Vaccine since it would only be one dose. The events resulted in Hospitalisation. Therapeutic measures were taken as a result of fell, he was in pain, injured his shoulder. The outcome of the events were unknown.  No Follow-up attempts are needed, Information about Lot/batch number cannot be obtained.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after date of expiry) and NO ADVERSE EVENT (no adverse event) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 prophylaxis. The patient ever had COVID + test or diagnosis was unknown. The AE and both Acute and Chronic illnesses at the time of vaccination was unknown. The Allergies including medications, food, and other products was unknown. On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after date of expiry) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after date of expiry). No concomitant medications reported. It was reported that 7 doses of Moderna Covid-19 vaccine after the expiration date were administered. The date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was unknown. The AE cause patient to seek medical care that is office visit, Urgent care, ER, hospitalized was unknown. It was unknown if patient experienced a similar event in the past. The cause of death and was autopsy done was unknown. It was unknown if the symptoms improved or worsened.
experiencing symptoms of Bells Palsy /  diagnosed by her HCP with Bells Palsy on 2-3-2021; This case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th December 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 30th January 2021, 46 days after receiving Shingrix, the patient experienced bell's palsy (serious criteria GSK medically significant). The patient was treated with prednisone. On an unknown date, the outcome of the bell's palsy was not recovered/not resolved.   It was unknown if the reporter considered the bell's palsy to be related to Shingrix.  Additional details were provided as follows: The patient received 2nd dose of Shingrix and experienced bells palsy. The patient was treated with prednisolone for these symptoms. The reporter did not consent to follow up.
Patient arrived to facility for her 2nd dose appointment. Patient reported a first dose reaction  to lead nurse. Patient reported dizziness immediately after vaccination that lasted for 15 minutes and itchiness all over body 30 minutes after vaccination lasting 1-2 hours. Patient did not remember taking benadryl for symptoms. Patient reported allergies to the environment, eczema, attention deficit disorder, and cerebral palsy. Patient reported taking pepcid and zyrtec.  Lead nurse elevated situation to medical consult team. At 1500, medical consult team advised patient to receive Janssen Covid 19 Vaccine as her second dose. Lead nurse collected patient's contact information to schedule her for one dose of the Janssen Covid 19 Vaccine. Lead nurse educated patient on receiving Janssen Covid 19 Vaccine as her second dose, seeing an allergist, signs/symptoms of when to seek emergency care, and how to sign up on v-safe. At approximately 1505, patient left facility to self with unlabored respirations and steady gait.
consumer reports that 3 wks p/recvd flu vax, pt exp diarrhea which was not controlled w/imodium; prescribed Tetracycline & then Metronidazole;
After the 4th injection...2nd booster...chills, fever, headache, loss of appetite, severe joint pain, extreme fatigue
DIDN'T FEEL TOO WELL; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-AUG-2021, the patient experienced didn't feel too well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of didn't feel too well was not reported. This report was non-serious. This case, from the same reporter is linked to 20210845308.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On 21-DEC-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ, orally, lot # L008034, expiration date 05-AUG-2016 (strength and dose were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Missed dose; This spontaneous pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided. No concomitant medications were reported.
temp, chills lasting 30 minutes treated w/APAP, pt returned to nl 45 mins later;
patient developed 103 fever within 8 hours and continues with 103 fever up to day 5 with rash developing on day 6.
This spontaneous report was received from a other health professional refers to 2 different unspecified patients of unknown demographics. On 20-OCT-2014 the patient was vaccinated with PNEUMOVAX23 lot # J004747, expiry: 20-JUL_2014 (dosing regimen unspecified). No concomitant medications were reported. Healthcare worker stated that an expired doses of PNEUMOVA23 were administered to 2 different unspecified patients on 20-OCT-2014. No adverse effects reported. The outcome of the medication error and no adverse effects reported is unknown. There was no product quality complaint involved. Additional information has been requested.
joints became achy and continued to be extremely achy thru the night with extreme headache until about 6pm 1/6/21, ran a fever thru the night also Felt as though I had COVID again as was positive on 11/2/2020
Tired and sleepy - for the next couple of days right after the vaccine. June 14, I started getting on my right side - from cheek to toes - and my whole leg and is still in pain today. For the last three weeks - the pain level was from 9 or 10 out of 10. I missed work for three weeks. I can barely sleep at night - maybe for three to four hours because the pain would wake me up. Today was my first day after three weeks that I was able to go to work. Today the pain is 5 out of 10. No treatment at the hospital. They prescribed me with 800 mg of Ibuprofen - two pills at night. The medicine was not strong enough. The prescribed me cream on my neck. The day I went to pick up my prescription to the pharmacist advised me to take another brand - so found a generic brand for $25 instead of $525. The cream doesn't numb my leg or make me fill better. I was applying hot water in the shower on my neck and that helped a bit. Told me to watch videos to stretch and exercise my neck every day.